Nifty 50
Tools & Calculators
Stocks
F&O
Mutual Funds
Bajaj Finserv Healthcare Reg IDCW-P
as of 29 Jun 2026, 16:17 PM
Invested Amount
Est. Return
Total Value
rated by Value Research
Your principal will be at Very High Risk
Absolute Returns
CAGR
Equity / Debt / Cash Split
Equity
95.79%
Debt
0.25%
Cash
3.96%
Others
0.01%
Equity sector allocation
Basic Materials
4.37%
Consumer Defensive
2.65%
Financial Services
0.91%
Healthcare
87.26%
Industrials
0.59%
Others
4.22%
Asset Management Company

Nippon India Taiwan Equity Reg Gr
Equity
Min. Investment
₹500
Category Returns
30.37%
63.78%
3Y Returns
+63.78%

DSP Wld Gld Mng Ovrs Eq Omni FoF Gr
Equity
Min. Investment
₹100
Category Returns
30.37%
63.78%
3Y Returns
+45.98%

DSP Wld Gld Mng Ovrs Eq Omni FoF IDCW-R
Equity
Min. Investment
₹100
Category Returns
30.37%
63.78%
3Y Returns
+45.89%
Investment Objective of the Scheme
Key Features of The Fund
5-year return
-
Fund Manager
Nimesh Chandan
Risk Profile
Very High Risk
Expense Ratio
2.09%
Fund Size
₹332.52 Cr
Bajaj Finserv Healthcare Reg IDCW-P is currently priced at ₹10.52, as of 29 Jun 2026, 16:17 PM. The fund has recorded a change of ₹0.04 (0.35%), indicating its recent movement in the market.
Tracking NAV trends helps investors understand short-term price movement, while long-term performance gives a better picture of wealth creation potential.
Bajaj Finserv Healthcare Reg IDCW-P is an open-ended mutual fund that invests based on its stated objective and benchmark.
Key details:
Asset Size: ₹332.52 Cr
Expense Ratio: 2.09%
Cash Holding: 3.96%
Plan Type: Dividend
Benchmark: BSE Healthcare TR INR
Launch Date: 2024-12-27
Exit Load: 1.00
These factors help investors evaluate cost, scale, and fund positioning before making an investment decision.
Bajaj Finserv Healthcare Reg IDCW-P has delivered returns across multiple timeframes, reflecting its ability to perform across different market conditions.
Returns:
1 Month: 1.31%
3 Months: 13.51%
6 Months: 9.52%
1 Year: 11.01%
3 Years: -
5 Years: -
Short-term returns indicate recent momentum, while long-term returns show consistency and wealth creation ability.
Understanding risk is important before investing. Bajaj Finserv Healthcare Reg IDCW-P falls under: For investors in the 20–40 age group, selecting a fund with the right risk level is important based on financial goals, investment horizon, and comfort with market movements.
Risk Level: Very High Risk
The riskometer helps investors understand how stable or volatile the fund can be based on its investment strategy and asset allocation. Funds with higher risk levels may offer better return potential over time, but they can also experience sharper short-term fluctuations. This classification reflects the volatility associated with the fund. Higher risk funds may offer higher returns but come with greater fluctuations.
The asset allocation of Bajaj Finserv Healthcare Reg IDCW-P shows how investments are distributed across asset classes.
Equity Allocation: 95.79%
Cash Allocation: 3.96%
This allocation plays a key role in determining the fund’s risk and return profile.
Bajaj Finserv Healthcare Reg IDCW-P diversifies its investments across sectors to reduce risk.
Sector Holding Detail
Basic Materials: 4.37%
Consumer Defensive: 2.65%
Financial Services: 0.91%
Healthcare: 87.26%
Industrials: 0.59%
Sector allocation data helps investors understand which industries the fund is focusing on.
Bajaj Finserv Healthcare Reg IDCW-P is managed by:
AMC Name: Bajaj Finserv Asset Management Limited
A strong fund house with a proven track record can improve investor confidence.
Investors can start investing in Bajaj Finserv Healthcare Reg IDCW-P with:
Minimum Investment: ₹500
This makes the fund accessible for both beginners and experienced investors.
The Bajaj Finserv Healthcare Reg IDCW-P has invested the majority of its money in the stocks of the following companies:
| Company | Percentage of Portfolio |
|---|---|
| Divi's Laboratories Ltd | 9.07% |
| Apollo Hospitals Enterprise Ltd | 6.73% |
| Sun Pharmaceuticals Industries Ltd | 6.54% |
| Piramal Pharma Ltd | 6.51% |
| Aurobindo Pharma Ltd | 6.17% |
| Torrent Pharmaceuticals Ltd | 5.26% |
| Rubicon Research Ltd | 4.52% |
| Neuland Laboratories Ltd | 4.39% |
| Emcure Pharmaceuticals Ltd | 4.18% |
| Max Healthcare Institute Ltd Ordinary Shares | 3.68% |
| Fortis Healthcare Ltd | 3.36% |
| Zydus Wellness Ltd | 2.65% |
| Vijaya Diagnostic Centre Ltd | 2.43% |
| Ipca Laboratories Ltd | 2.31% |
| Shaily Engineering Plastics Ltd | 2.23% |
| Navin Fluorine International Ltd | 2.14% |
| Senores Pharmaceuticals Ltd | 2.05% |
| Laurus Labs Ltd | 2.05% |
| Sanofi Consumer Healthcare India Ltd | 1.91% |
| Glenmark Pharmaceuticals Ltd | 1.90% |
| Dr. Lal PathLabs Ltd | 1.70% |
| GlaxoSmithKline Pharmaceuticals Ltd | 1.58% |
| Bajaj Finserv Money Market Dir Gr | 1.55% |
| Biocon Ltd | 1.48% |
| Zydus Lifesciences Ltd | 1.46% |
| Abbott India Ltd | 1.40% |
| Medplus Health Services Ltd | 1.39% |
| Krishna Institute of Medical Sciences Ltd | 1.14% |
| Medi Assist Healthcare Services Ltd | 1.12% |
| Eris Lifesciences Ltd Registered Shs | 1.05% |
| Jubilant Pharmova Ltd | 1.05% |
| ICICI Prudential Life Insurance Co Ltd | 0.91% |
| AstraZeneca Pharma India Ltd | 0.85% |
| MTAR Technologies Ltd | 0.59% |
| Clearing Corporation Of India Ltd | 1.53% |
| Net Receivables / (Payables) | 1.13% |
| Godrej Consumer Products Ltd | - |
| Lupin Ltd | - |
| Emami Ltd | - |
The Bajaj Finserv Healthcare Reg IDCW-P has invested the majority of its money in the stocks of the following sectors -
| Company | Percentage of Portfolio |
|---|---|
| Basic Materials | 4.37% |
| Consumer Defensive | 2.65% |
| Financial Services | 0.91% |
| Healthcare | 87.26% |
| Industrials | 0.59% |
Investing in mutual funds is easy on HDFC SKY.
Follow these simple steps to invest in Bajaj Finserv Healthcare Reg IDCW-P:
By signing up I certify terms, conditions & privacy policy